— Publications

Half-year Report 2018

All financial reports

— Media releases

August 2, 2018

Valneva Delivers Strong IXIARO® Sales Growth and Reports Further Progress on Key R&D Programs in H1

Read more

— Financial calendar

Upcoming events
Q3 2018  Results
November 8, 2018

All dates

— Meet us

European Large & Midcap Event
October 8-9, Paris

Biotech made in Vienna: "From Landsteiner to global products for infectious disease control"
6th Semmering symposium
October 11-13, Vienna

World Vaccine Congress Europe
October 29-31, Lisbon

Stifel 2018 Healthcare Conference
Lyme Disease

Download brochure


— Our responsibility

Committed to people, protecting lives and the environment

Learn more

play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

Subscribe to our Newsletter


Contact Investor Relations


Please update your browser...